Abstract:
A method of controlling electrical energy in a battery-powered vehicle wherein the vehicle includes a battery and a traction motor is provided. The method includes electrically coupling an external source of electrical energy to a unitary, integrated traction motor controller/vehicle battery charge controller positioned on-board the vehicle, controlling electrical energy flow to a vehicle battery with the unitary, integrated traction motor controller/vehicle battery charge controller during a charging period, and controlling electrical energy flow to a vehicle traction motor that is operable to propel the vehicle with the unitary, integrated traction motor controller/vehicle battery charge controller during a transport period.
Abstract:
A hard hat with attached glasses including a hard hat including a dome portion, the dome portion having an interior surface defining a dome space for receiving a wearer's head and said interior surface including a generally vertical front portion, a pair of glasses and a connection system connecting said pair of glasses to said hard hat, the connection system adapted to allow adjustment of the position of the glasses inside said dome space and down out of said dome space and pivotable about a substantially horizontal axis.
Abstract:
The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with cyclooxygenase-2 mediated disorders. Compounds of particular interest are benzopyrans and their analogs defined by formula 1 Wherein Z, X, R1, R2, R3, and R4 are as described in the specification.
Abstract:
The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with cyclooxygenase-2 mediated disorders. Compounds of particular interest are benzopyrans and their analogs defined by formula 1 Wherein Z, X, R1, R2, R3, and R4 are as described in the specification.
Abstract:
The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with cyclooxygenase-2 mediated disorders. Compounds of particular interest are benzopyrans and their analogs defined by formula 1 Wherein Z, X, R1, R 2, R3, and R4 are as described in the specification.